Does postoperative inflammation or sepsis generate neutrophil extracellular traps that influence colorectal cancer progression? A systematic review.


Journal

Surgery open science
ISSN: 2589-8450
Titre abrégé: Surg Open Sci
Pays: United States
ID NLM: 101768812

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 30 06 2019
revised: 17 12 2019
accepted: 31 12 2019
entrez: 6 8 2020
pubmed: 6 8 2020
medline: 6 8 2020
Statut: epublish

Résumé

Colorectal cancer is the third most common cancer worldwide. Almost half of those that have a potentially curative resection go on to develop metastatic disease. A recognized risk for recurrence is perioperative systemic inflammation and sepsis. Neutrophil extracellular traps have been implicated as promotors of tumor progression. We aimed to examine the evidence in the literature for an association between neutrophil extracellular traps and postoperative metastasis in colorectal cancer. Studies published between 2000 and December 2018 that examined the role of neutrophil extracellular traps in sepsis and inflammation in colorectal cancer and in relation to tumor-related outcomes were identified through a database search of Cochrane, CINAHL, and MEDLINE. Quality and bias assessment was carried out by 2 reviewers. Of 8,940 screened and of the 30 studies included, 21 were observational, 5 were in vivo experimental, 1 was in vitro, and 3 used a combination of these approaches. There is clear evidence from the literature that presence of a preoperative systemic inflammatory response predicts cancer recurrence following potentially curative resection, but the evidence for association of sepsis and progression is lacking. There is robust experimental evidence in murine models showing that neutrophil extracellular traps are present in sepsis and are associated with cancer progression. Some human observational studies corroborate the prognostic significance of neutrophil extracellular traps in progression of colorectal cancer. Further human studies are needed to translate the experimental evidence and to definitively associate sepsis and neutrophil extracellular traps with poor colorectal cancer-specific outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Colorectal cancer is the third most common cancer worldwide. Almost half of those that have a potentially curative resection go on to develop metastatic disease. A recognized risk for recurrence is perioperative systemic inflammation and sepsis. Neutrophil extracellular traps have been implicated as promotors of tumor progression. We aimed to examine the evidence in the literature for an association between neutrophil extracellular traps and postoperative metastasis in colorectal cancer.
MATERIALS AND METHODS METHODS
Studies published between 2000 and December 2018 that examined the role of neutrophil extracellular traps in sepsis and inflammation in colorectal cancer and in relation to tumor-related outcomes were identified through a database search of Cochrane, CINAHL, and MEDLINE. Quality and bias assessment was carried out by 2 reviewers.
RESULTS RESULTS
Of 8,940 screened and of the 30 studies included, 21 were observational, 5 were in vivo experimental, 1 was in vitro, and 3 used a combination of these approaches.
CONCLUSION CONCLUSIONS
There is clear evidence from the literature that presence of a preoperative systemic inflammatory response predicts cancer recurrence following potentially curative resection, but the evidence for association of sepsis and progression is lacking. There is robust experimental evidence in murine models showing that neutrophil extracellular traps are present in sepsis and are associated with cancer progression. Some human observational studies corroborate the prognostic significance of neutrophil extracellular traps in progression of colorectal cancer. Further human studies are needed to translate the experimental evidence and to definitively associate sepsis and neutrophil extracellular traps with poor colorectal cancer-specific outcomes.

Identifiants

pubmed: 32754708
doi: 10.1016/j.sopen.2019.12.005
pii: S2589-8450(20)30005-1
pmc: PMC7391903
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

57-69

Informations de copyright

© 2020 The Authors.

Références

Clin Colorectal Cancer. 2015 Sep;14(3):185-91
pubmed: 25882598
J Immunol. 2010 Dec 15;185(12):7413-25
pubmed: 21098229
Sci Transl Med. 2016 Oct 19;8(361):361ra138
pubmed: 27798263
Int J Cancer. 2017 May 15;140(10):2321-2330
pubmed: 28177522
Ann Surg. 2018 Jun;267(6):1119-1125
pubmed: 28394869
Ann Am Thorac Soc. 2017 Jun;14(6):929-936
pubmed: 28324671
Br J Surg. 2003 Feb;90(2):215-9
pubmed: 12555298
Oncogene. 2017 May 4;36(18):2483-2490
pubmed: 27941879
J Crit Care. 2016 Feb;31(1):48-53
pubmed: 26507291
Chest. 1995 Feb;107(2 Suppl):65S-70S
pubmed: 7842816
Science. 2018 Sep 28;361(6409):
pubmed: 30262472
Shock. 2008 Oct;30(4):352-8
pubmed: 18317404
Br J Surg. 2012 Feb;99(2):287-94
pubmed: 22086662
Crit Care. 2012 Aug 13;16(4):R151
pubmed: 22889177
Adv Exp Med Biol. 2013;756:1-8
pubmed: 22836612
Cancer Biol Ther. 2015;16(5):699-708
pubmed: 25807199
PLoS One. 2014 May 15;9(5):e97784
pubmed: 24831032
Ann Surg. 2011 May;253(5):890-9
pubmed: 21394013
PLoS One. 2014 Nov 05;9(11):e111888
pubmed: 25372699
BMC Cancer. 2017 Nov 10;17(1):744
pubmed: 29126400
World J Surg. 2017 Jan;41(1):277-284
pubmed: 27743072
J Surg Res. 2017 Dec;220:410-418.e1
pubmed: 28890131
Clin Colon Rectal Surg. 2006 Nov;19(4):228-36
pubmed: 20011326
JAMA. 1992 Apr 8;267(14):1947-51
pubmed: 1548827
J Gastrointest Surg. 2018 Sep;22(9):1611-1618
pubmed: 29687424
J Cell Biol. 2012 Sep 3;198(5):773-83
pubmed: 22945932
Ann Surg. 2017 Aug;266(2):311-317
pubmed: 27631770
JAMA. 2011 Jun 8;305(22):2335-42
pubmed: 21642686
Scand J Immunol. 2016 Dec;84(6):317-322
pubmed: 27667737
Ann Surg Oncol. 2014 Nov;21(12):3938-46
pubmed: 24866438
Ann Surg Oncol. 2013 Jul;20(7):2156-65
pubmed: 23456317
Br J Cancer. 2005 Feb 28;92(4):651-4
pubmed: 15700032
PLoS One. 2018 Jan 11;13(1):e0191231
pubmed: 29324871
Am J Surg. 2009 Apr;197(4):544-9
pubmed: 18614139
Colorectal Dis. 2013 Mar;15(3):323-8
pubmed: 22958479
Br J Surg. 2007 Aug;94(8):1028-32
pubmed: 17437250
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Int J Inflam. 2017;2017:4915062
pubmed: 28828191
N Engl J Med. 2011 Aug 11;365(6):518-26
pubmed: 21830966
Nat Med. 2012 Sep;18(9):1386-93
pubmed: 22922410
Dig Dis Sci. 2015 Aug;60(8):2477-87
pubmed: 25840921
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Acta Oncol. 2013 Nov;52(8):1691-8
pubmed: 24102179
Eur J Cancer. 2011 Nov;47(17):2633-41
pubmed: 21724383
Sci Rep. 2016 Apr 14;6:24517
pubmed: 27075165
Colorectal Dis. 2012 Oct;14(10):e701-7
pubmed: 22731833
Nat Commun. 2018 Nov 30;9(1):5116
pubmed: 30504805
J Clin Invest. 2013 Jul 1;:
pubmed: 23863628
Dis Colon Rectum. 2002 Mar;45(3):316-21
pubmed: 12068187
Nat Med. 2009 Jun;15(6):623-5
pubmed: 19448636
Mediators Inflamm. 2012;2012:149560
pubmed: 22315507
Med Oncol. 2015 May;32(5):144
pubmed: 25807934
J Orthop Res. 2009 Nov;27(11):1401-7
pubmed: 19422041
Ann Surg Oncol. 2017 Oct;24(11):3289-3299
pubmed: 28608118
J Immunol. 2012 Sep 15;189(6):2689-95
pubmed: 22956760
Tumour Biol. 2016 Nov;37(11):14355-14361
pubmed: 27614687
Clin Chim Acta. 2016 Aug 1;459:89-93
pubmed: 27259468
Br J Cancer. 2015 Apr 14;112(8):1306-13
pubmed: 25867263
Cell Host Microbe. 2012 Sep 13;12(3):324-33
pubmed: 22980329
Ann Surg. 2010 Feb;251(2):389-90; author reply 390-1
pubmed: 20040845
Br J Surg. 2003 Sep;90(9):1131-6
pubmed: 12945082

Auteurs

Georgia M Carroll (GM)

Division of Surgery, John Hunter Hospital, New South Wales, Australia.
School of Medicine and Public Health, University of Newcastle, New South Wales, Australia.
Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

Grace L Burns (GL)

Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
School of Biomedical Sciences and Pharmacy, University of Newcastle, New South Wales, Australia.

Joel A Petit (JA)

Division of Surgery, John Hunter Hospital, New South Wales, Australia.
School of Medicine and Public Health, University of Newcastle, New South Wales, Australia.
Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

Marjorie M Walker (MM)

School of Medicine and Public Health, University of Newcastle, New South Wales, Australia.
Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

Andrea Mathe (A)

Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
School of Biomedical Sciences and Pharmacy, University of Newcastle, New South Wales, Australia.

Stephen R Smith (SR)

Division of Surgery, John Hunter Hospital, New South Wales, Australia.
School of Medicine and Public Health, University of Newcastle, New South Wales, Australia.

Simon Keely (S)

Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
School of Biomedical Sciences and Pharmacy, University of Newcastle, New South Wales, Australia.

Peter G Pockney (PG)

Division of Surgery, John Hunter Hospital, New South Wales, Australia.
School of Medicine and Public Health, University of Newcastle, New South Wales, Australia.

Classifications MeSH